Biosante Pharmaceuticals (BPAX)
Create an Alert
1.22
-0.04 -3.17%
NASDAQ
Jun 19, 8:00PM
BATS Real time
Currency in USD
Biosante Pharmaceuticals Debt to Equity Ratio:
0.3138 for March 31, 2013Biosante Pharmaceuticals Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.3138 |
| Dec. 31, 2012 | 0.2798 |
| Sept. 30, 2012 | 0.2352 |
| June 30, 2012 | 0.3389 |
| March 31, 2012 | 0.2762 |
| Dec. 31, 2011 | 0.4585 |
| Sept. 30, 2011 | 0.4359 |
| June 30, 2011 | 1.713 |
| March 31, 2011 | 0.7341 |
| Dec. 31, 2010 | 0.9687 |
| Sept. 30, 2010 | 1.20 |
| June 30, 2010 | 0.6936 |
| March 31, 2010 | 0.7861 |
| Dec. 31, 2009 | 1.053 |
| Sept. 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| Dec. 31, 2008 | 0.00 |
| Sept. 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
BPAX Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| Repros Therapeutics | 0.00 |
| Teva Pharmaceutical Industries | 0.5573 |
| Eli Lilly and Company | 0.3652 |
BPAX Debt to Equity Ratio Rankings
| Overall |
73rd percentile 4433 of 16782 |
| Sector |
63rd percentile 518 of 1410 in Healthcare |
| Industry |
56th percentile 197 of 454 in Biotechnology |
BPAX Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.000 | Jun 2008 |
| Maximum | 1.713 | Jun 2011 |
| Average | 0.4744 |
